ストックスクリーナーアプリを入手
30.16
2.97%
-0.775
前日終値:
$30.93
開ける：
$30.38
24時間の取引高:
17,703
Relative Volume:
0.34
時価総額：
$375.08M
収益：
$9.71M
当期純損益:
$-29.96M
株価収益率:
-8.6652
EPS:
-3.48
ネットキャッシュフロー:
$-14.79M
1週間 パフォーマンス:
-6.60%
1か月 パフォーマンス:
-10.10%
6か月 パフォーマンス:
+20.04%
1年 パフォーマンス:
-0.40%
1日の値動き範囲:
$29.63
$31.16
1週間の範囲:
$29.07
$33.50
52週間の値動き範囲:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
XOMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
30.29 | 385.49M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.09 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.58 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.44 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
896.57 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-17 | 開始されました | The Benchmark Company | Buy |
| 2024-04-29 | 開始されました | Leerink Partners | Outperform |
| 2021-09-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-06-29 | 開始されました | Aegis Capital | Buy |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-10-17 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-05 | アップグレード | Wedbush | Neutral → Outperform |
| 2017-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-14 | ダウングレード | Wedbush | Outperform → Neutral |
| 2016-03-11 | 繰り返されました | Wedbush | Outperform |
| 2015-07-23 | ダウングレード | Jefferies | Buy → Hold |
| 2015-07-22 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 再開されました | ROTH Capital | Buy |
| 2014-04-29 | アップグレード | MLV & Co | Hold → Buy |
| 2014-03-11 | ダウングレード | MLV & Co | Buy → Hold |
| 2014-03-05 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2013-10-31 | 繰り返されました | MLV & Co | Buy |
| 2013-05-09 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2012-05-14 | 開始されました | Cowen & Co | Outperform |
| 2011-03-31 | 繰り返されました | MLV Capital | Buy |
| 2011-03-23 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2011-01-06 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2011-01-04 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Xoma Royalty Corp (XOMA) 最新ニュース
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Canada
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance
XOMA Royalty completes acquisition of Mural Oncology - Investing.com
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Why XOMA Royalty Corporation (X0M1) stock could be top winnerJuly 2025 Outlook & Weekly High Return Stock Opportunities - Newser
Will XOMA Royalty Corporation (X0M1) stock test record highs in 20252025 Price Action Summary & Weekly High Return Forecasts - Newser
Why XOMA Royalty Corporation (X0M1) stock appeals to dividend investorsEarnings Recap Report & Capital Efficient Trade Techniques - Newser
What earnings margins imply for XOMA Royalty Corporation(X0M) stockIPO Watch & Risk Managed Investment Strategies - Newser
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com India
Mural Oncology Announces Sanction of the Scheme by the High Court - The Manila Times
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology Announces Sanction of the Scheme by the High Court - Benzinga
Is XOMA Royalty Corporation (X0M1) stock a defensive play amid uncertaintyMarket Activity Summary & Weekly Watchlist for Consistent Profits - Newser
How robust is XOMA Royalty Corporation(X0M) stock financial position - Newser
XOMA Royalty (NASDAQ:XOMA) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Mural Oncology Shareholders To Receive $2.035 Cash Per Share In XOMA Royalty Acquisition - Nasdaq
XOMA Royalty to acquire Mural Oncology for $2.035 per share By Investing.com - Investing.com Nigeria
XOMA Royalty to acquire Mural Oncology for $2.035 per share - Investing.com India
Mural Oncology announces final cash consideration payable on acquisition close - TipRanks
Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - The Manila Times
Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan
XOMA (NASDAQ:XOMAP) Trading 0.2% Higher – Should You Buy? - Defense World
Xoma completes $24.9M acquisition of cash-strapped Lava Therapeutics - The Business Journals
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - ADVFN
Xoma announces closing of transactions to acquire Lava Therapeutics - TipRanks
XOMA Royalty completes acquisition of LAVA Therapeutics - Investing.com
[8-K] XOMA Royalty Corp Reports Material Event - Stock Titan
XOMA Royalty completes acquisition of LAVA Therapeutics By Investing.com - Investing.com UK
XOMA Royalty Corporation Completes Acquisition of LAVA Therapeutics N.V. - Quiver Quantitative
XOMA Royalty (Nasdaq: XOMA) completes LAVA deal; investors get $1.04 plus CVR - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
How XOMA Royalty Corporation (X0M1) stock reacts to Fed tighteningJobs Report & High Accuracy Trade Alerts - newser.com
How XOMA Royalty Corporation stock performs after earningsEarnings Recap Report & Long-Term Safe Investment Ideas - newser.com
How XOMA Royalty Corporation(X0M) stock behaves under inflation pressure2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Is XOMA Royalty Corporation stock a safe buy before earningsRate Hike & Verified Momentum Stock Watchlist - newser.com
Is XOMA Royalty Corporation (X0M1) stock attractive for dividend growthNew Guidance & High Conviction Investment Ideas - newser.com
Can XOMA Royalty Corporation (X0M1) stock attract analyst upgrades2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Why XOMA Royalty Corporation stock remains undervaluedJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
How XOMA Royalty Corporation stock compares to market leadersTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com
XOMA Royalty's (NASDAQ:XOMA) Earnings Aren't As Good As They Appear - Yahoo Finance
How strong is XOMA Royalty Corporation stock revenue growthEarnings Performance Report & Weekly High Return Stock Opportunities - newser.com
Why millennials buy XOMA Royalty Corporation (X0M1) stock2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Will XOMA Royalty Corporation stock keep outperforming rivals2025 Short Interest & Fast Gaining Stock Reports - newser.com
XOMAO | XOMA Royalty Corporation Depositary Stock Data, Price & News - Quiver Quantitative
XOMAO Stock Institutional Owners - Quiver Quantitative
LuxembourgXOMA Royalty Acquires LAVA Therapeutics - Mondaq
Xoma turns its attention to Repare | ApexOncoClinical Trials news and analysis - Oncology Pipeline
XOMAP | XOMA Royalty Corporation 8.625% Stock Data, Price & News - Quiver Quantitative
Q4 EPS Estimates for XOMA Royalty Cut by Leerink Partnrs - Defense World
Xoma Royalty Corp (XOMA) 財務データ
収益
当期純利益
現金流量
EPS
Xoma Royalty Corp (XOMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hughes Owen | Chief Executive Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
35,567 |
0 |
98,268 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 19 '25 |
Option Exercise |
0.00 |
11,846 |
0 |
34,409 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 22 '25 |
Sale |
35.99 |
4,330 |
155,820 |
30,079 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
3,033 |
0 |
12,134 |
| Montano Maricel Perea | Chief Legal Officer |
Sep 10 '25 |
Option Exercise |
0.00 |
9,101 |
0 |
9,101 |
| Sitko Bradley | Chief Investment Officer |
Jun 30 '25 |
Buy |
25.39 |
2,000 |
50,780 |
7,045 |
| Hughes Owen | Chief Executive Officer |
May 19 '25 |
Option Exercise |
0.00 |
53,359 |
0 |
88,338 |
| Hughes Owen | Chief Executive Officer |
May 20 '25 |
Sale |
25.38 |
25,637 |
650,667 |
62,701 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 19 '25 |
Option Exercise |
0.00 |
17,773 |
0 |
33,045 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 20 '25 |
Sale |
25.38 |
10,482 |
266,033 |
22,563 |
0.83%
0.99%
大文字化:
|
ボリューム (24 時間):